Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-4521

Single-particle
3.3 Å
EMD-4521
3D View Gallery
Deposition: 01/01/2019
Map released: 02/10/2019
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-4521
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 6qd8 summary report (pdf.gz) Map and 6qd8 FULL report (pdf.gz)
EMICSS annotations (xml)

EM structure of a EBOV-GP bound to 4M0368 neutralizing antibody

EMD-4521

Single-particle
3.3 Å
EMD-4521
3D View Gallery
Deposition: 01/01/2019
Map released: 02/10/2019
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus, Homo sapiens
Sample: EBOV-GP in complex with neutralizing 3T0331 antibody
Fitted models: 6qd8

Deposition Authors: Diskin R , Cohen-Dvashi H

rVSV-ZEBOV induces a polyclonal and convergent B cell response with potent Ebola virus-neutralizing antibodies
Diskin R , Cohen-Dvashi H, Ehrhardt S, Zehner M, Krahling V, Kreer C, Dahlke C, Ercanoglu MS, Gruell H, Addo MM, Becker S, Klein F
(2019) Nat Med
ISSN: 1078-8956
ASTM: NAMEFI